BioStem Technologies, Inc. (BSEM)
3.54
+0.04
(+1.14%)
USD |
NASDAQ |
Sep 02, 16:00
3.65
+0.11
(+3.11%)
Pre-Market: 08:28
BioStem Technologies Cash from Investing (Quarterly) : -0.0561M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0561M |
| March 31, 2026 | -15.02M |
| December 31, 2025 | -0.4368M |
| September 30, 2025 | -1.168M |
| June 30, 2025 | -0.3324M |
| March 31, 2025 | -0.1647M |
| December 31, 2024 | -0.1313M |
| September 30, 2024 | -1.370M |
| June 30, 2024 | -0.1632M |
| March 31, 2024 | -0.0124M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.0406M |
| June 30, 2023 | -0.0046M |
| March 31, 2023 | -0.1651M |
| December 31, 2022 | -0.0704M |
| September 30, 2022 | -0.0628M |
| June 30, 2022 | -0.2193M |
| March 31, 2022 | -0.1169M |
| December 31, 2021 | 0.0283M |
| September 30, 2021 | -0.0088M |
| June 30, 2021 | -0.5491M |
| March 31, 2021 | 0.5217M |
| December 31, 2020 | 0.3572M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | -0.0099M |
| December 31, 2018 | 0.2001M |
| September 30, 2018 | -0.4517M |
| June 30, 2018 | -0.0172M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -0.0044M |
| September 30, 2017 | -0.0368M |
| June 30, 2017 | -0.0324M |
| March 31, 2017 | -0.0593M |
| December 31, 2016 | -0.0126M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -0.6248M |
| March 31, 2016 | 0.0164M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -0.021M |
| CorMedix, Inc. | -0.561M |
| Eloxx Pharmaceuticals, Inc. | 0.00 |
| Cannabis Global, Inc. | 0.00 |
| Breakthrough Chemistry, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.538M |
| Cash from Financing (Quarterly) | -1.146M |
| Free Cash Flow | -8.832M |
| Free Cash Flow Per Share (Quarterly) | -0.3229 |
| Free Cash Flow to Equity (Quarterly) | -3.539M |
| Free Cash Flow to Firm (Quarterly) | -5.595M |
| Free Cash Flow Yield | -13.45% |